More than 27% ESCC patients had somatic mutations in DNA-repair pathway genes, including BRCA2 (3%), TDG (3%), FANCM (3%), RIF (3%), and ATM (3%). The gene discussed is BRCA2; the disease is esophageal squamous cell carcinoma.